ABSTRACT. This study investigated the nature and mechanism of juglone-induced apoptosis in the human breast cancer cell line MCF-7. The inhibitory effect of juglone on MCF-7 cell growth was evaluated by the dimethylthiazol tetrazolium assay. Morphological apoptotic changes were characterized using an inverted microscope, Hoechst 33258 fluorescence staining, and Giemsa staining. The rate of cell apoptosis, intracellular levels of reactive oxygen species (ROS), and mitochondrial membrane potential were detected using flow cytometry. Intracellular Ca 2+ concentrations were detected using laser scanning confocal fluorescence microscopy. Expression of the proteins Bcl-2, Bax, and cytochrome C was assessed by western blotting. Caspase-3 activity was quantified using a caspase-3 activity kit. Juglone inhibited the growth of MCF-7 cell line with an IC50 of 11.99 µM. The rates of MCF-7 cell apoptosis at 24 h after exposure to 5, 10, and 20 µM juglone were 9.29, 20.67, and 28.39%, respectively; compared to unexposed cells, juglone-exposed cells exhibited significant elevation in intracellular ROS level, decrease in mitochondrial membrane potential, and increase in intracellular Ca 2+ concentration. Juglone upregulated the expression of Bax, and downregulated the expression of Bcl-2, promoting the release of cytochrome C, thereby upregulating the activity of caspase-3. The results suggest that the mechanism of juglone-induced apoptosis in MCF-7 cells is characterized by elevated ROS levels, reduced Bcl-2 expression, increased Bax expression, decreased mitochondrial membrane potential, increased intracellular Ca 2+ concentration, outer mitochondrial-membrane rupture, cytochrome C release, and caspase-3 activation.
INTRODUCTION
Breast cancer is the most common malignancy in women, and has become a substantial threat to women's health. The clinical treatment of breast cancer includes surgery and radiotherapy, both of which can cause significant physiological and psychological harm to patients. Heat therapy and Chinese medicine represent conservative treatment approaches that carry a lower risk of harm to patients, but are associated with reduced clinical effectiveness. Development of effective breast cancer treatments with low toxicity is thus a priority (Jaradat et al., 2016) .
Juglone (5-hydroxy-1,4-naphthoquinone) has recently been shown to have strong antitumor activity (Kamei et al., 1998; Ji et al., 2011) . Juglone was shown to exhibit strong anticancer activity against mouse ascites hepatoma, mouse S180 solid sarcoma, SGC-7901 human gastric cancer cells, HL-60 human leukemia cells, and HCT-15 human colon carcinoma cells (Segura-Aguilar et al., 1992; Kamei et al., 1998; Ji et al., 2011) . The anticancer activity of juglone was found rely on the ability of the compound to kill tumor cells directly, induce apoptosis, inhibit the S-phase of the cell cycle, block the potassium channel (in human peripheral blood lymphocytes), inhibit the expression of the p53 gene, and induce fast phosphorylation of histone H2AX. In other diseases, Juglone was found to be associated with production of reactive oxygen species (ROS) (Ji et al., 2011) , and this may also be the case in various cancers.
Few data are available on the anticancer activity of juglone in human breast cancer cells. In order to add to the theoretical basis guiding the development of new drugs and their clinical application in the treatment of breast cancer, we studied the influence of juglone on the apoptosis of MCF-7 cells.
MATERIAL AND METHODS

Reagents
The following reagents were used in the experimental procedures: juglone with a purity of 97% (Tianjin Yifang Ltd., China); hydroxycamptothecin (HCPT; Yellow Boulder Feiyun Pharmaceutical Co. Ltd., China); RPMI-1640 cell culture medium (Gibco, USA); 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT; Beijing Soledad Symbol Technologies Ltd., China); N-acetyl-l-cysteine (NAC; Tianjin Yifang Ltd.); dimethyl sulfoxide (DMSO), trypsin, propidium iodide (PI; Sigma-Aldrich, USA); Fluo-3-acetoxymethyl ester (Fluo-3/AM; Molecular probe Co., USA); JC-1 mitochondrial membrane potential assay kit (Pik-Day Institute of Biotechnology, China); rhodamine 123 (Sigma-Aldrich); Giemsa stain (Ltd. Noble Ryder, China); mouse anti-human Bcl-2 antibody, mouse anti-human Bax antibody, mouse anti-β-actin antibody (Santa Cruz Biotechnology, USA); fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG antibody (Wuhan Boster Biological Engineering Co., Ltd., China); western blotting assay kit and cell immunoprecipitation lysates (Pik-Day Institute of Biotechnology); mouse anti-human cytochrome C antibody (Santa Cruz Biotechnology); caspase-3 activity assay kit (Beyotime Institute of Biotechnology, China); Ac-DEVD-pNA caspase-3 substrate (BioVision, USA).
Instruments
The following instruments and materials were used in the experimental procedures: CO-150-type CO 2 cell culture incubator (NBS Co., USA), EPICS XL flow cytometer (Beckman Coulter Co., USA), CKX-41-32 inverted microscope (Olympus, Japan), fluorescence microscope (Leica, Germany), SW-CJ-2f super clean workbench (Suzhou Purification Plant, China), ELISA 680 microplate reader (Bio-Rad, USA), SP-2 confocal laser scanning microscope (Leica), 0.22-mm nitrocellulose membranes (Sigma-Aldrich), electrophoresis system (Bio-Rad, 165-8001), GIS-2019 gel imaging system (Tanon Science & Technology Co., Ltd., China), automatic pipette (Gilson, France).
Cell lines and culture conditions
The MCF-7 cell line was provided by the Harbin University of Commerce (Harbin, China). Cells were cultured in RPMI-1640 medium supplemented with 10% fetal calf serum and maintained at 37°C in a 5% CO 2 atmosphere. The culture medium was changed every 2-3 days.
Cell proliferation assay
MCF-7 cells in the logarithmic growth phase were harvested by trypsin digestion. The resulting cell suspension was adjusted to a concentration of 1 x 10 4 /mL, and a 100-µL aliquot was pipetted into each well of a 96-well culture plate. After culturing for 24 h, 100 µL juglone solution with or without 10 mM NAC was added to each well, to a final juglone concentration of 6.25, 12.5, 25, or 50 M. HCPT (40 µM) was added to each positive control well, and 100 µL RPMI-1640 was added to each blank control well. After culturing for 72 h at 37°C, the supernatant was removed, replaced with 100 µL 0.5 mg/mL MTT; the plates were oscillated briefly and cultured for an additional 4 h. The plates were then removed from the incubator, and MTT was replaced with 150 µL DMSO; the plates were oscillated to dissolve the formazan, and the absorbance at 570 nm was read using an ELISA plate reader.
Morphology of MCF-7 cells
MCF-7 cells in logarithmic growth were harvested and, after adjusting to a concentration of 1 x 10 5 /mL, the suspensions were seeded into six-well culture plates. After incubating for 24 h, 1 mL juglone solution with or without 10 mM NAC was added to a final juglone concentration of 5, 10, or 20 µM. HCPT (40 µM) in 1 mL RPMI-1640 was added to wells assigned to the control group. After culturing for 24 h, cell morphology was evaluated using an inverted microscope.
Giemsa staining
The cell samples used for evaluation of morphology were fixed in paraformaldehyde at 4°C, washed with phosphate-buffered saline (PBS), and incubated at room temperature for 30 min in the dark with 1 mL Giemsa stain. After washing twice with PBS, the cells were observed using an inverted microscope.
Fluorescence microscopy
The cell samples used for evaluation of morphology were fixed in methanol and glacial acetic acid at 4°C for 1 h and washed with PBS. The cells were then incubated for 30 min in the dark at 37°C in a water bath with 1 mL Hoechst 33258 nucleic acid stain, and prepared for observation by fluorescence microscopy.
Flow cytometric assay of cells undergoing apoptosis
MCF-7 cells in logarithmic growth phase were plated at 1 mL/well in six-well plates. After culturing for 24 h, 1 mL juglone was added to each well to a final concentration of 5, 10, or 20 µM; HCPT (1 mL) was added to a final concentration of 40 µM. The same volume of RPMI-1640 was added to the control wells. The plates were incubated for 24 h; cells were harvested, washed with PBS, and adjusted to a final concentration of 1 x 10 5 /mL. The cell suspensions were centrifuged for 5 min at 2000 g, and the supernatants were discarded. The cells were washed three times with PBS, fixed in ice-cold ethanol (70%), and kept overnight at -20°C. After washing three times with PBS, PI dye solution was added, and the cells were kept at 4°C in the dark for 30 min. After collection on 300-mm mesh filters, the cell suspensions were assayed by flow cytometry.
Detection of ROS levels
Cells were harvested, suspended in RPMI-1640 containing dichloro-dihydrofluorescein diacetate (DCFH-DA, 1:1000) to a final concentration of 10 µM. The cell suspensions containing diluted DCFH-DA were incubated at 37°C in a water bath in the dark for 20 min, and then washed three times with serum-free RPMI-1640. After collection on 300-mm mesh filters, ROS levels were assayed by flow cytometry.
Mitochondrial membrane assay
After treating the cells with 5, 10, or 20 µM juglone, HCPT (40 µM) or RPMI-1640 was added. After 24 h, cells were harvested, resuspended in 500 µL PBS plus 500 µL rhodamine 123 (20 mg/mL), to a final concentration of 10 mg/mL rhodamine 123, and kept for 30 min in the dark. The cells were collected after centrifugation at 2000 rpm for 5 min, washed once with PBS, and then resuspended in 800 µL PBS. After collection on 300-mm mesh filters, the mitochondrial membranes were assayed by flow cytometry.
Intracellular Ca 2+ concentration
Cells were cultured for 24 h, collected, and resuspended in 500 µL aliquots of PBS. A 200-µL volume of Fluo-3/AM (4 mg/mL) was added, followed by incubation at 37°C in a water bath for 30 min in the dark. Fluo-3/AM was then removed by centrifugation at 2000g; the cells were washed once in PBS, and resuspended in 400 µL PBS for observation by laser confocal microscopy to detect Ca 2+ concentration.
Caspase-3 activity assay
The cells were treated with 5, 10, or 20 mM juglone solution, with or without 10 mM NAC, and with HCPT (60 mM) or RPMI-1640, and incubated for 24 h. Lysates of 2 x 10 6 cells each were prepared by incubation with 100 mL lysis buffer for 15 min on ice, centrifuged at 20,000 g for 15 min at 4°C, and then collected in ice-cold centrifuge tubes. A blank solution containing 90 mL reaction buffer plus 10 mL Ac-DEVD-pNA and test solutions including a 10 mL sample from each group, 80 mL reaction buffer, and 10 mL Ac-DEVD-pNA, were incubated in 96-well plates for 2 h at 37°C. Caspase-3 activity was measured at 405 nm using a microplate reader.
Western blot assay of Bcl-2 and Bax expression
The western blot assay was conducted as follows. Briefly, cells were treated and harvested, transferred to 1.5-mL tubes, centrifuged at 20,000 g, and washed twice with PBS. A 100-mL volume of ice-cold cell-lysis buffer was added to the sample over 30 min in an ice water bath. Lysates were centrifuged at 25,600 g for 10 min at 4°C. The supernatants were collected and stored at -20°C until assayed. Electrophoresis was carried out on a mini-Protean 3 system (Bio-Rad).
Flow cytometric assay of cytochrome C protein in MCF-7 cells
Cells were treated and collected as described above, fixed in 4% (w/v) paraformaldehyde for 40 min, centrifuged 20,000 g, and rinsed twice with PBS. After permeabilization with 2 mL 0.1% Triton X-100 for 15 min, the samples were centrifuged at 20,000 g and rinsed twice with PBS. A 1-mL volume of 1% BSA was added to the centrifuge tubes, and, after 1 h, the samples were centrifuged at 20,000 g and the supernatant was discarded. Mouse anti-cytochrome C antibody (1:200) was added, and, following 1 h incubation at 37°C, the cells were washed with PBS. FITCconjugated goat anti-mouse IgG antibody (1:50) was added. After 30 min in the dark at ambient temperature, the cells were washed and re-suspended in 800 µL PBS. After collection on 300-mm mesh filters, the cells were assayed by flow cytometry. Each experiment was repeated three times.
Statistical analysis
Data are reported as means ± standard deviation. The groups of cells were compared by one-way analysis of variance, followed by the Fisher F test. The significance of betweengroup differences was determined by the Student unpaired-sample t-test. Values of P ≤ 0.05 were considered significant.
RESULTS
Juglone-inhibited proliferation of MCF-7 cells
Inhibition of MCF-7 cell proliferation increased with juglone concentration, and the inhibition was stronger in the presence of juglone alone than in the presence of both juglone and NAC (Figure 1 ). Juglone inhibited MCF-7 cell proliferation with an IC50 of 11.99 µM; in the presence of NAC, the IC50 of juglone-induced inhibition was 49.75 µM. Figure 1 . Juglone-induced inhibition of MCF-7 cell proliferation, in the presence or absence of NAC. Green = juglone group; purple = juglone+NAC group; X-axis = juglone concentration; Y-axis = inhibition rate. **Compared with juglone group (P < 0.01). In both groups, the rate of apoptosis increases with juglone concentration. Apoptosis is more pronounced in the juglone group.
Juglone-induced morphological changes of MCF-7 cells
Examination using the inverted microscope revealed that the cells in the control group had grown adherently to the plate, and had intact cell membranes. In the juglone group, the density of plate-adherent cells decreased with increasing juglone concentration, and the cell membrane appeared wrinkled. Most cells in the high juglone-concentration group appeared collapsed, with incomplete cell morphology. In the juglone+NAC group, juglone-induced inhibition of MCF-7 cells was significantly lower than in the juglone group, irrespective of juglone concentration (Figure 2) . Figure 2 . Morphological changes in MCF-7 cells at 24 h after juglone exposure. Top = inverted microscope images; middle = Giemsa staining images; bottom = fluorescence microscope images. Apoptosis-specific morphological changes were observed in all cases (red arrows), with higher incidence in the juglone and juglone+NAC groups than in the control group, and highest incidence in the HCPT group. The number of apoptotic cells increased with juglone concentration. This was also observed in the juglone+NAC group, but to a lesser extent than in the juglone group with the corresponding juglone concentration. Scale bar: 50 µm.
Juglone-induced apoptosis of MCF-7 cells
As shown in Figure 3 , the apoptosis rate in positive controls was 30.26 ± 0.07%. The apoptosis rates increased with juglone concentration, from 9.29 ± 0.09% at 5 µM, to 20.67 ± 0.16% at 10 µM, and 28.39 ± 0.37% at 20 µM. In the presence of NAC, the apoptosis rate for each juglone concentration was significantly decreased: 5.60 ± 0.37% at 5 µM, 11.35 ± 0.59% at 10 µM, and 21.85 ± 0.32% at 20 µM (all with P < 0.01).
Effect of juglone on ROS levels in MCF-7 cells
As shown in Figure 4 , the ROS level in negative controls was 22.68 ± 0.17%, and 95.34 ± 0.21% in positive controls. ROS levels in juglone-treated cells were 50.46 ± 0.39% at 5 µM, 60.34 ± 0.26% at 10 µM, and 95.47 ± 0.49% at 5 µM. Differences between the juglone and control groups were significant (P < 0.01). ROS levels in cells treated with both juglone and NAC were 30.76 ± 0.23%, 32.79 ± 0.11%, and 40.56 ± 0.21% respectively, and were not significantly different from control rates (P < 0.01). The presence of NAC significantly reduced ROS levels for each of the tested juglone concentrations (P < 0.01). (72 h). The apoptosis rates in the juglone group were lower than those in the HCPT group (H), and higher than those in the control and juglone+NAC group. Moreover, apoptosis rate increased with juglone concentration, and was higher than that in the juglone+NAC group for the same juglone concentration. **Comparison between assays with matching juglone concentrations (P < 0.01).
Juglone effect on mitochondrial membrane potential
As shown in Figure 5 , cell mitochondrial membrane potential in blank controls was 86.62 ± 0.10 and 61.84 ± 0.96% in positive controls. In juglone-treated cells, the mitochondrial membrane potentials were 74.26 ± 0.12% at 5 µM, 57.44 ± 0.21% at 10 µM, and 47.33 ± 0.16% at 20 µM, all of which were significantly lower that the blank control value (P < 0.01). In the NAC combined treatment group, the mitochondrial membrane potentials were 82.65 ± 0.28, 67.35 ± 0.21, 54.50 ± 0.33% respectively, and were significantly lower than the blank control and significantly higher than the corresponding juglone-only values (all P < 0.01). Flow cytometry and statistical analysis of the effect of juglone on ROS levels in MCF-7 cells. The green column represents the juglone group, the purple column represents juglone+NAC group, the X-axis represents the concentration and the Y-axis represents ROS level. ROS level in all juglone alone group and juglone+NAC group was higher than control group and lower than HCPT group. With the concentration increased, the ROS level increased gradually in both group, while that of juglone alone group was higher than juglone combined NAC group. **Comparison against control (P < 0.01). ^^Compared with matched doses of juglone P < 0.01.
Effect of juglone on Ca 2+ concentration of MCF-7 cells
As shown in Figure 6 , intracellular Ca 2+ concentration in positive controls was significantly higher than in blank controls (P < 0.01), and was significantly higher in juglonetreated cells than in the blank controls (P < 0.01). The intracellular Ca 2+ concentration also increased with increase of juglone concentration. Ca 2+ concentration was significantly higher in NAC combined-treatment groups than in blank controls, but significantly lower than in the corresponding juglone-only groups (P < 0.01).
Effect of juglone on caspase 3 activity in MCF-7 cells
As shown in Figure 7 , juglone activated caspase 3 in a concentration-dependent manner. Caspase-3 activity in HPCP group was significantly higher than in the control group, and was 12.12, 28.79, and 48.48% higher in cells treated with 5, 10, and 20 µM juglone, respectively, than in the controls (P < 0.01). Caspase-3 activity of cells in the NAC combinedtreatment groups was 4.55, 18.18, and 30.30% higher than the control cell values (P < 0.01) and significantly lower than the values in cells treated with juglone only (P < 0.01). Mitochondrial membrane potential of both Juglone group and juglone+NAC group was lower than control group, and that of juglone alone group was lower than juglone combined NAC group. **Compared with Control P < 0.01. ^^Compared with matched doses of juglone P < 0.01. Mitochondrial membrane potential of both juglone group and juglone+NAC group was higher than control group. The membrane potential of the juglone group was higher than juglone+NAC group. **Compared with Control P < 0.01. ^^Compared with matched doses of juglone P < 0.01. Figure 7 . Effect of juglone on caspase 3 activity of MCF-7 cells The green column represents juglone group, the purple column represents juglone+NAC group, the X axis represents the concentration and the Y axis represents casepase-3 activity. Casepase-3 activity in all juglone alone group and juglone+NAC group was higher than control group and lower than HCPT group. With the concentration increased, the ROS level increased gradually in both group, while that of juglone alone group was higher than juglone combined NAC group. **Compared with Control P < 0.01. ^^Compared with matched doses of juglone P < 0.01.
Effect of juglone on the expression of Bcl-2 and Bax proteins in MCF-7cells
As shown in Figure 8 , the expression of Bcl-2 protein decreased significantly with increasing juglone concentration compared with the control cells (P < 0.01), and expression was lower in cells treated with juglone alone than in cells treated with NAC plus juglone (P < 0.01). Bax protein expression was significantly higher after juglone exposure than in both the control cells and in cells given NAC with juglone (P < 0.01). Protein expression was reported relative to the control and is shown in the histogram (P < 0.01). The green column represents juglone group and the purple column represents juglone+NAC group. The Bcl-2 activity of juglone group was lower than corresponding juglone+NAC group. The Bax activity of juglone group was higher than corresponding juglone+NAC group. **Compared with Control P < 0.01. ^^Compared with matched doses of juglone P < 0.01.
Effect of juglone on cytochrome C protein expression in MCF-7 cells
The expression of cytochrome C protein was significantly higher in juglone treated cells (5, 10, 20 mM) than in the control cells and in cells treated with NAC plus juglone ( Figure  9 ). There was a positive correlation between cytochrome-c level and juglone concentration. 
DISCUSSION
To our knowledge, this is the first report regarding the effect of juglone on MCF-7 cells. The MTT assay showed that juglone suppressed the proliferation of MCF-7 cells, and that NAC antagonized that effect. Giemsa and fluorescence staining showed that the morphology of juglone-exposed MCF-7 cells was consistent with apoptosis.
In addition to the morphological evidence, flow cytometry showed that apoptosis in each treatment group reached a peak at 72 h after juglone treatment, and that the increase in apoptosis rate was accompanied by increased density, which is consistent with previous reports (Ji et al., 2011) . In the presence of NAC, juglone-induced apoptosis rate decreased significantly. Previous research has shown that juglone is converted into a semiquinone radical via single electron oxidoreduction (Inbaraj and Chignell, 2004) . The semiquinone radical can rapidly convert molecular oxygen into a superoxide anion (O 2 -), which then produces H 2 O 2 enzymatically; the latter can be changed into a highly active hydroxyl free radical (OH˙) via the Fenton reaction. The species O 2 -, H 2 O 2 , and OH˙ are all ROS (Bolton et al., 2000; Klaus et al., 2010) . ROS can either regulate the physiological activity of cells, or cause oxidative damage to molecules and cell organelles (Srinivas et al., 2004; Gomathinayagam et al., 2008) . In the present study, flow cytometry showed that juglone increased the levels of ROS in MCF-7 cells, in agreement with previous findings (Inbaraj and Chignell, 2004) , but that this effect was reduced in the presence of NAC. Increased ROS levels likely interfere with the functioning of the mitochondrial electron transport chain, and decrease mitochondrial transmembrane potential by reducing the oxidation state of the mitochondrial inner membrane and by damaging mitochondrial DNA and several key proteins (Hall et al., 2015) .
Decrease of mitochondrial electron transport is due, in part, to oxidative injury and change in intracellular Ca 2+ concentration (Kolupaev et al., 2014) . In the early phase of apoptosis, mitochondrial Ca 2+ release leads to an increase in intracellular Ca 2+ levels (Akopova et al., 2013) . Sustained high levels of ROS likely promote destruction of organelle and cell membranes, as well as redistribution and continuous intracellular accumulation of Ca 2+ (Li et al., 2014) . Thus, the generation of ROS and the increase in intracellular Ca 2+ concentration are interconnected during the progression of apoptosis. The results of laser scanning confocal microscopy demonstrated that juglone increased the Ca 2+ concentration in MCF-7 cells, while NAC antagonized this effect. Juglone also reduced Bcl-2 expression, increased Bax expression, and released cytochrome-c from the mitochondria into the cytoplasm; NAC antagonized these effects as well. The Bcl-2 protein family includes factors that regulate apoptosis (Zimmermann et al., 2007) and act intracellularly by changing the mitochondrial membrane potential and the permeability of mitochondrial membranes, thus affecting the release of proteins that recruit the apoptotic machinery (Chakraborty et al., 2014) .
Bax promotes the opening of mitochondrial permeability transition pores (PTPs) to induce apoptosis, while Bcl-2 inhibits the opening of PTPs and prevents apoptosis (Liu et al., 2013; Al-Fatlawi et al., 2014) . The decrease in Bcl-2 expression and increase in Bax expression likely promotes the opening of mitochondrial PTPs, inflow of Ca 2+ into the mitochondrial matrix, imbalance of osmotic pressure, and decrease in mitochondrial membrane potential (Cheng et al., 2011) . The opening of mitochondrial PTPs leads to relative hypertonicity of the mitochondria, expansion of the mitochondrial matrix, disruption of the adventitia, and release of apoptotic proteins such as cytochrome C, a component of the respiratory chain (Bonora and Pinton, 2014) . When mitochondrial PTPs open and mitochondria are injured, cytochrome C flow out into the cytoplasm (Huang et al., 2001) , further promoting apoptosis by recruitment of caspases (Naoi et al., 2013) .
Overall, the results obtained in our study showed that juglone inhibited the proliferation of MCF-7 human breast cancer cells and promoted apoptosis by elevating ROS levels, reducing Bcl-2 expression, increasing Bax expression, decreasing mitochondrial membrane potential, increasing intracellular Ca 2+ concentrations, promoting the rupture of the outer mitochondrial membrane, releasing cytochrome C, and activating caspase-3. These results provide valuable new insight into the mechanism of juglone-induced apoptosis, with applications in the treatment of breast cancer.
